Yerevan
Tbilisi
Moscow
Paris
Los Angeles
Beijing
English
Հայերեն Русский
Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Timeline
Idram Becomes a Partner of “Little Mher”Unibank has launched instant transfers by phone number Unisport Crowned Armenian Futsal Premier League ChampionOn May 30, "Unisport" will compete for the title of the Armenian championWith IDBank’s Support, Ian Gillan and Tony Iommi Awards Established at Gyumri Music School No. 6An unforgettable day instead of toys: June 1st guide from Idram&IDBankUnibank Issues Perpetual Bonds with a 13.25% Annual Yield for Shareholders IDBank Presented It’s Vision for Social Responsibility at Impacture 2026Unibank will not increase fixed-adjustable interest rates on loans secured by real estate Ucom General Director Ralph Yirikian Participated in the Impacture 2026 Conference“We are switching you to 5G, type a command”: IDBank warns about a fraud disguised as a “network update”Ucom and staff.am Bring Together Armenia’s Business Leaders at Executive Offsite Vol.1 Ameriabank and ADB Signed a $100 Million Agreement to Expand Micro, Small, and Medium-Sized Enterprise and Green Finance in ArmeniaLove Is… card from Unibank can win a trip to Paris Learn by Playing. A Series of Financial Literacy Games with Idram, IDBank and “Novosti-Armenia”Ucom and the Microsoft Innovation Center Collaborate on Cybersecurity EducationUnisport – Armenian Futsal Cup holderSummer starts with iced coffee, what if it brings bonuses too? Idram&IDBank AraratBank reduces loan interest rates for around 400 reliable SME customersTeam Holding Announces the Launch of the Third and Final Placement Phase of USD Bonds. Underwriter - Freedom Broker Armenia
All Timeline »
Life

1 in 4 people face side effects after getting COVID-19 vaccine

One in four people experiences side effects after being vaccinated against coronavirus. These are mostly minor side effects like pain at the injection site or headache, Lancet Infectious Diseases reported.

Analysis of data from the ZOE COVID Symptom Study, conducted by researchers at King's College London, found that side effects in the general population after vaccination with Pfizer and AstraZeneca were much lower than those reported in the trials.

The study also reported a significant reduction in infection rates from 12 to 21 days after the first dose of Pfizer (58% reduction) and AstraZeneca (39% reduction) compared to controls. The reduction in infection at least 21 days after the first dose is 69% for Pfizer and 60% for AstraZeneca.

Research has shown that:

  • 25.4% of vaccinated people reported one or more systemic side effects, while 66.2% reported one or more local side effects.
  • 13.5% of participants reported side effects after the first dose of Pfizer, 22.0% after the second dose of Pfizer, and 33.7% after the first dose of AstraZeneca.
  • The most common systemic side effect was a headache. 7.8% of people reported headaches after the first dose of Pfizer and 13.2% after the second dose of Pfizer. 22.8% of people who received the first dose of the AstraZeneca vaccine reported headaches.
  • The second most common systemic side effect was fatigue. 8.4% and 14.4% of participants reported fatigue after the first and second doses of the Pfizer vaccine, and 21.1% reported fatigue after the first dose of the AstraZeneca vaccine.
  • The most common localized side effect was soreness: 57.2% and 50.9% after the first and second doses of Pfizer vaccine and 49.3% after the first dose of AstraZeneca vaccine.

Side effects were more common in people under the age of 55 and in women.